Harvard Catalyst brings together the intellectual force, technologies, and clinical expertise of Harvard University and its affiliates and partners to reduce the burden of human illness. This course focuses on the principles and practices of translational medicine as they apply to the development of a new drug (small molecules and/or biologics), device, or diagnostic. Goodwin partner Theresa Kavanaugh will be presenting at the Harvard Catalyst’s Introduction to Translational Medicine (ITTM). For more information, please visit: https://catalyst.harvard.edu/services/ittm/.
Speaking Engagements September 14, 2016